chemXplore tracks 107 projects in United Kingdom, of which 36 are active.
29 new construction, 5 expansion, and 1 revamp / retrofit.
7 of the active projects carry no start-up date yet.
Owners and developers: Velocys (2), Alfanar Group (1), Altalto Limited (1), Associated British Ports (1), BioWatt Facilities Management Limited (1), Carbon Neutral Fuels (1)
Investors: Trafigura (2), GlaxoSmithKline plc (1), His Majesty's Government of the United Kingdom of Great Britain and Northern Ireland (1), Hydrasun Limited (1), Lloyds Banking Group plc (1), Mitsubishi Chemical Group (1)
Contractors, licensors, and offtakers are recorded on 26 of these 36 projects For subscribers
Targeting: Hydrogen (15), Sustainable Aviation Fuel (8), Carbon dioxide (7), Ammonia (2), Diesel, fuels (2), Methane (2)
Drop-in on 15 Oct to view early plans for a 40-acre SAF plant at Siddick producing ~42,000 t/yr and creating 500 construction and 150+ permanent jobs.
Oral ICOTYDE maintains durable skin clearance through Week 112 and yields high site‑specific clearance rates for scalp, genital, hand/foot and nails.
Joins the national bioenergy body and signs an MoU to explore bioSAF from captured sugarcane waste in Queensland; links to international scale-up pipeline.
MRI‑PDFF subanalysis (n=55) found mean liver fat fell from 8.8% to 3.1% at week 72; 88.5% with baseline liver fat >5% reached <5%.
VOYAGER shows Vabysmo yields vision gains, marked CST reductions and reduced retinal fluid across nAMD, DME and RVO in routine practice, with no new safety signals.
Additional purchase orders for PEM electrolyser stacks tied to US, UK and French submarine programs; bookings in Q3 2026; deliveries slated for 2027–2028.
VOYAGER real-world data show Vabysmo improves vision and reduces retinal thickness across wet AMD, DME and RVO, with rapid anatomical drying and no new safety signals.
Ro telehealth real-world data: mean 4.1% weight loss at three months; 40.7% reached ≥5% loss; obesity (BMI≥30) prevalence fell 21.6 percentage points; N=194.
fMRI shows reduced ‘food noise’ and cravings; trials report major weight loss, reductions in abdominal/liver/pancreas fat and preliminary bone‑marker reassurance.
Preferred electrolyzer supplier for over 1 GW of e‑SAF projects; initial 280 MW GenEco will produce ~110 t/day renewable H2 for jet fuel at Port of Vordingborg; ENDOR moving to FID.
active / all projects
